FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication
Even two days per week of compound resistance movements, squats, deadlifts, rows, presses, provides meaningful muscle preservation stimulus
10.2337/db07-0563 108
The recombinant shingles vaccine is associated with lower risk of dementia , Nature Medicine | doi:10.1038/s41591-024-03201-5 Copyright by GrrlScientist | hosted by Forbes | LinkTr.ee Socials: Bluesky | CounterSocial | Gab | LinkedIn | Mastodon Science | Spoutible | SubStack | Threads | Tribel | Tumblr | Twitter
As of April 2026, Jorie Weight Loss Center does not prescribe or offer brand-name GLP-1 medications (semaglutide, tirzepatide) or compounded versions